NATURAL CAPSULES
|
NATURAL CAPSULES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 5.95 | 19.89 | 19.56 | 10.99 | 1.38 |
| CEPS(Rs) | 15.24 | 27.66 | 27.03 | 14.76 | 6.55 |
| DPS(Rs) | - | 1.00 | 1.00 | 1.00 | 0.60 |
| Book NAV/Share(Rs) | 218.39 | 132.85 | 118.34 | 99.63 | 89.24 |
| Tax Rate(%) | 31.03 | 26.19 | 28.23 | 24.50 | 37.44 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.18 | 19.91 | 17.98 | 13.96 | 8.85 |
| EBIT Margin(%) | 8.57 | 16.66 | 15.89 | 12.20 | 3.70 |
| Pre Tax Margin(%) | 5.18 | 14.50 | 14.35 | 11.51 | 2.23 |
| PAT Margin (%) | 3.57 | 10.70 | 10.30 | 8.69 | 1.39 |
| Cash Profit Margin (%) | 9.15 | 14.88 | 14.03 | 14.11 | 8.09 |
| Performance Ratios | |||||
| ROA(%) | 1.67 | 8.14 | 10.65 | 8.05 | 1.16 |
| ROE(%) | 3.40 | 17.89 | 19.18 | 11.74 | 1.54 |
| ROCE(%) | 5.00 | 16.18 | 20.75 | 14.52 | 3.71 |
| Asset Turnover(x) | 0.47 | 0.76 | 1.03 | 0.93 | 0.83 |
| Sales/Fixed Asset(x) | 0.99 | 1.32 | 1.36 | 1.02 | 0.91 |
| Working Capital/Sales(x) | 3.29 | 4.99 | 4.38 | 4.88 | 3.12 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.01 | 0.76 | 0.74 | 0.98 | 1.10 |
| Receivable days | 125.17 | 83.04 | 71.61 | 130.95 | 185.47 |
| Inventory Days | 32.74 | 14.22 | 15.12 | 27.29 | 28.45 |
| Payable days | 134.19 | 100.67 | 97.82 | 112.34 | 99.07 |
| Valuation Parameters | |||||
| PER(x) | 51.33 | 19.76 | 23.63 | 8.03 | 19.58 |
| PCE(x) | 20.05 | 14.21 | 17.10 | 5.98 | 4.11 |
| Price/Book(x) | 1.40 | 2.96 | 3.91 | 1.08 | 0.37 |
| Yield(%) | - | 0.25 | 0.22 | 0.93 | 1.83 |
| EV/Net Sales(x) | 2.45 | 2.63 | 2.75 | 0.94 | 0.42 |
| EV/Core EBITDA(x) | 17.31 | 12.64 | 14.01 | 6.33 | 4.03 |
| EV/EBIT(x) | 28.58 | 15.81 | 17.30 | 7.73 | 11.33 |
| EV/CE(x) | 1.22 | 2.07 | 2.26 | 0.77 | 0.35 |
| M Cap / Sales | 1.83 | 2.11 | 2.40 | 0.84 | 0.33 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -9.84 | 27.62 | 69.86 | 29.18 | 2.97 |
| Core EBITDA Growth(%) | -38.80 | 35.54 | 124.10 | 84.85 | 3.39 |
| EBIT Growth(%) | -53.61 | 33.78 | 121.35 | 325.70 | -12.31 |
| PAT Growth(%) | -69.89 | 32.57 | 101.29 | 706.04 | -55.35 |
| EPS Growth(%) | -70.07 | 1.66 | 78.04 | 698.55 | -55.35 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.53 | 0.78 | 0.63 | 0.16 | 0.11 |
| Current Ratio(x) | 1.62 | 1.52 | 1.69 | 1.49 | 2.10 |
| Quick Ratio(x) | 1.37 | 1.38 | 1.59 | 1.29 | 1.80 |
| Interest Cover(x) | 2.53 | 7.70 | 10.31 | 17.84 | 2.51 |
| Total Debt/Mcap(x) | 0.38 | 0.26 | 0.12 | 0.14 | 0.31 |
Compare Financial Ratios of peers of NATURAL CAPSULES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATURAL CAPSULES | ₹298.0 Cr | 9.8% | 6.9% | -23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
| CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics | |
NATURAL CAPSULES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATURAL CAPSULES | 9.8% |
6.9% |
-23% |
| SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses
